主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RGNX
#2557
REGENXBIO Inc.
9.040
0
+8.00%
版块:
基础:
利润货币:
日范围
年范围
日变化
+8.00%
每月变动
-5.88%
6个月变化
-32.69%
年变化
-32.69%
前一天收盘价
8.370
0
Open
9.040
0
Bid
Ask
Low
9.040
0
High
9.040
0
交易量
78
市场
股票
医疗保健
RGNX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
新闻
Stifel就FDA局长言论评论uniQure股票
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
REGENXBIO: Cautiously Bullish After FDA Setbacks (NASDAQ:RGNX)
Regenxbio stock price target lowered to $32 at H.C. Wainwright after FDA rejection
Intel, Wells Fargo among market cap stock movers on Tuesday
Netflix and Oracle among market cap stock movers on Tuesday
高盛下调Regenxbio目标价,因RGX-121项目受挫
Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback
REGENXBIO股价下跌,因FDA拒绝亨特综合征基因疗法